Cargando…
Is Antiplatelet Therapy Contraindicated After Platelet-Rich Plasma Treatment? A Narrative Review
BACKGROUND: Antiplatelet therapies are often withheld before and after platelet-rich plasma product (PRPP) administration due to theoretical concerns that therapies that inhibit the function of platelets would inhibit the effects of PRPP. PURPOSE/HYPOTHESIS: The purpose of this study was to evaluate...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202276/ https://www.ncbi.nlm.nih.gov/pubmed/34179207 http://dx.doi.org/10.1177/23259671211010510 |